ID   DECR2_HUMAN             Reviewed;         292 AA.
AC   Q9NUI1; Q6ZRS7; Q96ET0;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 134.
DE   RecName: Full=Peroxisomal 2,4-dienoyl-CoA reductase;
DE            Short=pDCR;
DE            EC=1.3.1.34;
DE   AltName: Full=2,4-dienoyl-CoA reductase 2;
DE   AltName: Full=Short chain dehydrogenase/reductase family 17C member 1;
GN   Name=DECR2; Synonyms=PDCR, SDR17C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11514237; DOI=10.1016/S1388-1981(01)00141-X;
RA   De Nys K., Meyhi E., Mannaerts G.P., Fransen M., Van Veldhoven P.P.;
RT   "Characterisation of human peroxisomal 2,4-dienoyl-CoA reductase.";
RL   Biochim. Biophys. Acta 1533:66-72(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K.,
RA   Tufarelli C., Kearney L., Buckle V.J., Doggett N.A., Flint J.,
RA   Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2
RT   Mb of the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-151 AND LYS-291, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 2-278 IN COMPLEX WITH
RP   HEXADIENOYL COA AND NADP, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, AND MUTAGENESIS OF ASP-86; ASP-137; ASP-186 AND
RP   ASP-268.
RX   PubMed=22745130; DOI=10.1074/jbc.M112.385351;
RA   Hua T., Wu D., Ding W., Wang J., Shaw N., Liu Z.J.;
RT   "Studies of human 2,4-dienoyl CoA reductase shed new light on
RT   peroxisomal beta-oxidation of unsaturated fatty acids.";
RL   J. Biol. Chem. 287:28956-28965(2012).
CC   -!- FUNCTION: Auxiliary enzyme of beta-oxidation. Participates in the
CC       degradation of unsaturated fatty enoyl-CoA esters having double
CC       bonds in both even- and odd-numbered positions in peroxisome.
CC       Catalyzes the NADP-dependent reduction of 2,4-dienoyl-CoA to yield
CC       trans-3-enoyl-CoA. Has activity towards short and medium chain
CC       2,4-dienoyl-CoAs, but also towards 2,4,7,10,13,16,19-
CC       docosaheptaenoyl-CoA, suggesting that it does not constitute a
CC       rate limiting step in the peroxisomal degradation of
CC       docosahexaenoic acid.
CC   -!- CATALYTIC ACTIVITY: Trans-2,3-didehydroacyl-CoA + NADP(+) =
CC       trans,trans-2,3,4,5-tetradehydroacyl-CoA + NADPH.
CC       {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=59 uM for 2,4-hexadienoyl-CoA {ECO:0000269|PubMed:11514237,
CC         ECO:0000269|PubMed:22745130};
CC         KM=6 uM for 2,4-decadienoyl-CoA {ECO:0000269|PubMed:11514237,
CC         ECO:0000269|PubMed:22745130};
CC         KM=102 uM for 2,4,7,10,13,16,19-docosaheptaenoyl-CoA
CC         {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130};
CC         Vmax=1.75 umol/min/mg enzyme toward 2,4-Hexadienoyl CoA
CC         {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130};
CC         Vmax=1.37 umol/min/mg enzyme toward 2,4-Decadienoyl CoA
CC         {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130};
CC   -!- SUBUNIT: Monomer, dimer and oligomer.
CC       {ECO:0000269|PubMed:22745130}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NUI1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NUI1-2; Sequence=VSP_013630, VSP_013631, VSP_013632;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9NUI1-3; Sequence=VSP_013629;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. 2,4-dienoyl-CoA reductase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ293009; CAC05664.1; -; mRNA.
DR   EMBL; AE006463; AAK61231.1; -; Genomic_DNA.
DR   EMBL; AK128012; BAC87232.1; -; mRNA.
DR   EMBL; AL023881; CAB92744.1; -; Genomic_DNA.
DR   EMBL; BC010740; AAH10740.1; -; mRNA.
DR   EMBL; BC011968; AAH11968.1; -; mRNA.
DR   CCDS; CCDS10409.1; -. [Q9NUI1-1]
DR   RefSeq; NP_065715.1; NM_020664.3. [Q9NUI1-1]
DR   UniGene; Hs.628831; -.
DR   PDB; 4FC6; X-ray; 2.10 A; A/B/C/D=2-278.
DR   PDB; 4FC7; X-ray; 1.84 A; A/B/C/D=2-278.
DR   PDBsum; 4FC6; -.
DR   PDBsum; 4FC7; -.
DR   ProteinModelPortal; Q9NUI1; -.
DR   SMR; Q9NUI1; -.
DR   BioGrid; 117525; 14.
DR   IntAct; Q9NUI1; 10.
DR   MINT; MINT-2819394; -.
DR   STRING; 9606.ENSP00000219481; -.
DR   SwissLipids; SLP:000001050; -.
DR   iPTMnet; Q9NUI1; -.
DR   PhosphoSitePlus; Q9NUI1; -.
DR   BioMuta; DECR2; -.
DR   DMDM; 84029527; -.
DR   EPD; Q9NUI1; -.
DR   MaxQB; Q9NUI1; -.
DR   PaxDb; Q9NUI1; -.
DR   PeptideAtlas; Q9NUI1; -.
DR   PRIDE; Q9NUI1; -.
DR   DNASU; 26063; -.
DR   Ensembl; ENST00000219481; ENSP00000219481; ENSG00000242612. [Q9NUI1-1]
DR   Ensembl; ENST00000439661; ENSP00000399697; ENSG00000242612. [Q9NUI1-2]
DR   Ensembl; ENST00000613476; ENSP00000481547; ENSG00000274296. [Q9NUI1-1]
DR   Ensembl; ENST00000631856; ENSP00000488824; ENSG00000274296. [Q9NUI1-2]
DR   GeneID; 26063; -.
DR   KEGG; hsa:26063; -.
DR   UCSC; uc002chb.4; human. [Q9NUI1-1]
DR   CTD; 26063; -.
DR   GeneCards; DECR2; -.
DR   H-InvDB; HIX0012648; -.
DR   H-InvDB; HIX0079832; -.
DR   H-InvDB; HIX0173312; -.
DR   HGNC; HGNC:2754; DECR2.
DR   HPA; HPA047631; -.
DR   MIM; 615839; gene.
DR   neXtProt; NX_Q9NUI1; -.
DR   OpenTargets; ENSG00000242612; -.
DR   PharmGKB; PA27235; -.
DR   eggNOG; KOG0725; Eukaryota.
DR   eggNOG; COG1028; LUCA.
DR   GeneTree; ENSGT00760000118868; -.
DR   HOVERGEN; HBG100327; -.
DR   InParanoid; Q9NUI1; -.
DR   KO; K13237; -.
DR   OMA; DDTEGMR; -.
DR   OrthoDB; EOG091G0GO6; -.
DR   PhylomeDB; Q9NUI1; -.
DR   TreeFam; TF315256; -.
DR   BRENDA; 1.3.1.34; 2681.
DR   Reactome; R-HSA-535734; Fatty acid, triacylglycerol, and ketone body metabolism.
DR   ChiTaRS; DECR2; human.
DR   GeneWiki; DECR2; -.
DR   GenomeRNAi; 26063; -.
DR   PRO; PR:Q9NUI1; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000242612; -.
DR   CleanEx; HS_DECR2; -.
DR   ExpressionAtlas; Q9NUI1; baseline and differential.
DR   Genevisible; Q9NUI1; HS.
DR   GO; GO:0005778; C:peroxisomal membrane; TAS:Reactome.
DR   GO; GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0019166; F:trans-2-enoyl-CoA reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR002347; SDR_fam.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Fatty acid metabolism; Lipid metabolism; NADP; Oxidoreductase;
KW   Peroxisome; Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    292       Peroxisomal 2,4-dienoyl-CoA reductase.
FT                                /FTId=PRO_0000054559.
FT   NP_BIND      35     40       NADP. {ECO:0000269|PubMed:22745130}.
FT   NP_BIND      60     64       NADP. {ECO:0000269|PubMed:22745130}.
FT   NP_BIND     208    214       NADP. {ECO:0000269|PubMed:22745130}.
FT   REGION      126    128       Substrate binding.
FT   MOTIF       290    292       Microbody targeting signal.
FT                                {ECO:0000250}.
FT   BINDING      60     60       Substrate.
FT   BINDING      86     86       NADP. {ECO:0000269|PubMed:22745130}.
FT   BINDING      88     88       Substrate.
FT   BINDING     118    118       Substrate.
FT   BINDING     182    182       NADP. {ECO:0000269|PubMed:22745130}.
FT   BINDING     219    219       Substrate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     151    151       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     287    287       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     291    291       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     48       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_013629.
FT   VAR_SEQ      50     50       R -> RASEDQMGHCSSSGTCLAGVATFMVIVGKQPPNQKS
FT                                RETKEQGRQIPFVCVR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_013630.
FT   VAR_SEQ     114    160       AAGNFLCPAGALSFNAFKTVMDIDTSGTFNVSRVLYEKFFR
FT                                DHGGVI -> SSSSCGLPFCRCGRELPVPRWRLVLQRLQDR
FT                                DGHRYQRHLQCVSCAL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_013631.
FT   VAR_SEQ     161    292       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_013632.
FT   MUTAGEN      86     86       D->A: Reduces enzyme activity by 98%.
FT                                {ECO:0000269|PubMed:22745130}.
FT   MUTAGEN     137    137       D->A: Reduces enzyme activity by 97%.
FT                                {ECO:0000269|PubMed:22745130}.
FT   MUTAGEN     186    186       D->A: Reduces enzyme activity by about
FT                                95%. {ECO:0000269|PubMed:22745130}.
FT   MUTAGEN     268    268       D->A: Reduces enzyme activity by 97%.
FT                                {ECO:0000269|PubMed:22745130}.
FT   STRAND        9     12       {ECO:0000244|PDB:4FC7}.
FT   TURN         23     28       {ECO:0000244|PDB:4FC7}.
FT   STRAND       30     34       {ECO:0000244|PDB:4FC7}.
FT   TURN         35     37       {ECO:0000244|PDB:4FC7}.
FT   HELIX        39     49       {ECO:0000244|PDB:4FC7}.
FT   TURN         50     52       {ECO:0000244|PDB:4FC7}.
FT   STRAND       54     60       {ECO:0000244|PDB:4FC7}.
FT   HELIX        62     76       {ECO:0000244|PDB:4FC7}.
FT   STRAND       80     84       {ECO:0000244|PDB:4FC7}.
FT   HELIX        90    104       {ECO:0000244|PDB:4FC7}.
FT   STRAND      109    112       {ECO:0000244|PDB:4FC7}.
FT   HELIX       122    124       {ECO:0000244|PDB:4FC7}.
FT   HELIX       127    137       {ECO:0000244|PDB:4FC7}.
FT   HELIX       139    151       {ECO:0000244|PDB:4FC7}.
FT   HELIX       153    156       {ECO:0000244|PDB:4FC7}.
FT   STRAND      158    163       {ECO:0000244|PDB:4FC7}.
FT   HELIX       167    170       {ECO:0000244|PDB:4FC7}.
FT   HELIX       176    196       {ECO:0000244|PDB:4FC7}.
FT   HELIX       197    199       {ECO:0000244|PDB:4FC7}.
FT   STRAND      201    208       {ECO:0000244|PDB:4FC7}.
FT   STRAND      211    214       {ECO:0000244|PDB:4FC7}.
FT   HELIX       215    220       {ECO:0000244|PDB:4FC7}.
FT   HELIX       224    232       {ECO:0000244|PDB:4FC7}.
FT   HELIX       242    253       {ECO:0000244|PDB:4FC7}.
FT   HELIX       255    257       {ECO:0000244|PDB:4FC7}.
FT   STRAND      264    268       {ECO:0000244|PDB:4FC7}.
FT   HELIX       271    274       {ECO:0000244|PDB:4FC7}.
SQ   SEQUENCE   292 AA;  30778 MW;  9E7CD2995CE598D6 CRC64;
     MAQPPPDVEG DDCLPAYRHL FCPDLLRDKV AFITGGGSGI GFRIAEIFMR HGCHTVIASR
     SLPRVLTAAR KLAGATGRRC LPLSMDVRAP PAVMAAVDQA LKEFGRIDIL INCAAGNFLC
     PAGALSFNAF KTVMDIDTSG TFNVSRVLYE KFFRDHGGVI VNITATLGNR GQALQVHAGS
     AKAAVDAMTR HLAVEWGPQN IRVNSLAPGP ISGTEGLRRL GGPQASLSTK VTASPLQRLG
     NKTEIAHSVL YLASPLASYV TGAVLVADGG AWLTFPNGVK GLPDFASFSA KL
//
